Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: A prospective multicenter trial

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 4, 2009, Pages 370-376

  Wang, Wen Ping ^a   Wu, Ying ^b   Luo, Yan ^c   Li, Rui ^d   Zhou, Xiao Dong ^e   Zhang, Jun ^f   Qian, Chao Wen ^g   Tan, Xu Yan ^h   Xu, Qing Hua ⁱ   Wang, Yan ^j   Yuan, Jian Jun ^k  

^a FUDAN UNIVERSITY   (China)

^b SHENZHEN PEOPLE'S HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

^d SOUTHWEST HOSPITAL   (China)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f JILIN PROVINCIAL CANCER HOSPITAL   (China)

^g ZHEJIANG CANCER HOSPITAL   (China)

^h JIANGSU CANCER HOSPITAL   (China)

ⁱ THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

^j Henan Cancer Hospital   (China)

^k HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

more..

Author keywords

Characterization; Contrast enhanced ultrasonography; Focal liver lesions

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLINICAL TRIAL; CONTRAST ENHANCED ULTRASONOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; GOLD STANDARD; HUMAN; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CYST; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER NODULE; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHINA; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; TOMOGRAPHY, SPIRAL COMPUTED; YOUNG ADULT;

EID: 69249187733     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gaiani S, Volpe L, Piscaglia F, Bolondi L. Vascularity of liver tumours and recent advances in doppler ultrasound. J Hepatol 2001;34:474-482. (Pubitemid 32240830)
2. Reinhold C, Hammers L, Taylor CR, Quedens-Case CL, Holland CK, Taylor KJ. Characterization of focal hepatic lesions with duplex sonography: findings in 198 patients. AJR Am J Roentgenol 1995;164:1131-1135.
3. Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1990;154:509-514. (Pubitemid 20071599)
4. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000;216:411-417.
5. Schneider M, Arditi M, Barrau MB, Brochot J, Broillet A, Ventrone R, et al. BRI: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995;30:451-457.
6. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000;215:153-161. (Pubitemid 30190524)
7. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 2004;24:921-935. (Pubitemid 38943326)
8. Leen E, Horgan P. Ultrasound contrast agents for hepatic imaging with nonlinear modes. Curr Probl Diagn Radiol 2003;32:66-87. (Pubitemid 36437476)
9. Leen E, Moug SJ, Horgan P. Potential impact and utilization of ultrasound contrast media. Eur Radiol 2004; 14:16-24. (Pubitemid 40425143)
10. Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images - concordance of US scans with CT scans and MR images. Radiology 2007;242: 162-174. (Pubitemid 44956021)
11. Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420-430. (Pubitemid 38971282)
12. Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL, et al. Characterization of focal liver lesions using contrast- enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006;34:261-272.
13. Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol 2006;60:324-330.
14. Peschl R, Werle A, Mathis G. Differential diagnosis of focal liver lesions in signal-enhanced ultrasound using BR 1, a second-generation ultrasound signal enhancer. Dig Dis 2004;22:73-80. (Pubitemid 39070150)
15. von Herbay A, Vogt C, Willers R, Haussinger D. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004;23:1557-1568. (Pubitemid 39586861)
16. Strunk H, Borner N, Stuckmann G, Fröhlich E, Hadizadeh D. Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions. Rofo 2005;177:1394-1404.
17. Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove D, et al. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 2004;25:249-256. (Pubitemid 39128145)
18. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.
19. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
20. Bleuzen A, Tranquart F. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 2004;14:53-62. (Pubitemid 40425147)
21. Solbiati L, Cova L, Ierace T. Specificity of contrast- enhanced harmonic sonography for characterization of solid, incidentally detected focal liver lesions. Ultrasound Med Biol 2003;Suppl 29:S23.
22. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986;39:183-188.
23. Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol 1992;158:535-539.
24. Leifer DM, Middleton WD, Teefey SA, Menias CO, Leahy JR. Follow-up of patients at low risk for hepatic malignancy with a characteristic hemangioma at US. Radiology 2000;214:167-172.
25. Ohlsson B, Nilsson J, Stenram U, Akerman M, Tranberg KG. Percutaneous fine-needle aspiration cytology in the diagnosis and management of liver tumours. Br J Surg 2002;89:757-762. (Pubitemid 34595702)
26. Jain D. Diagnosis of hepatocellular carcinoma: fine needle aspiration cytology or needle core biopsy. J Clin Gastroenterol 2002;35:S101-108. (Pubitemid 35278647)
27. Ding H, Wang WP, Huang BJ, Wei RX, He NA, Qi Q, et al. Imaging of focal liver lesions: low-mechanical-index real- time ultrasonography with SonoVue. J Ultrasound Med 2005;24:285-297. (Pubitemid 40315955)
28. Catala V, Nicolau C, Vilana R, Pages M, Bianchi L, Sanchez M, et al. Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 2007;17:1066-1073. (Pubitemid 46766888)
29. Leen E, Ceccotti P, Kalogeropoulou C, Angerson WJ, Moug SJ, Horgan PG. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR Am J Roentgenol 2006;186:1551-1559. (Pubitemid 46112517)
30. Hohmann J, Skrok J, Puis R, Albrecht T. Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue. Rofo 2003;175:835-843. (Pubitemid 36806768)
31. Gaiani S, Celli N, Piscaglia F, Cecilioni L, Losinno F, Giangregorio F, et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004;41:421-426. (Pubitemid 39158751)
32. Solbiati L, Cova L, Kirn V, Tonolini M. Contrast-enhanced sonography is highly reliable and potentially cost-effective for characterizing focal liver lesions initially detected by unenhanced sonography. Radiological Society of North America;2004:426.